[G6PD deficiency among children under 7 years old from Yunnan with unique ethnic minority origin]

Li-qin Yao1, Tuan-biao Zou, Xing-tian Wang

  • 1Yunnan Maternal and Child Health Hospital, Kunming, P.R. China.

Insights

Glucose-6-phosphate dehydrogenase (G6PD) deficiency affects 2.5% of children in Yunnan, with higher rates in boys and ethnic minorities. This prevalence varies by region and is influenced by altitude and family history.

Area of Science:

  • Genetics
  • Epidemiology
  • Biochemistry

Context:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common inherited red blood cell disorder.
  • Yunnan province, China, has a diverse ethnic population, necessitating region-specific health data.
  • Understanding G6PD deficiency prevalence is crucial for public health management and genetic counseling.

Purpose:

  • To determine the epidemiological status of G6PD deficiency in children from Yunnan, China.
  • To analyze variations in G6PD deficiency rates based on gender, ethnicity, and geographic region.
  • To identify factors influencing G6PD deficiency occurrence in the studied population.

Summary:

  • A study of 11,759 children in Yunnan found a 2.5% G6PD deficiency detection rate.
  • Prevalence was significantly higher in boys (3.5%) than girls (1.4%) and varied among ethnic groups, with Han Chinese showing lower rates (0.7%) compared to ethnic minorities.
  • Altitude and family history were significant factors influencing G6PD deficiency rates.

Impact:

  • The findings highlight significant gender, ethnic, and regional disparities in G6PD deficiency prevalence in Yunnan.
  • Identified influencing factors like altitude and family history can aid in targeted screening and intervention strategies.
  • This epidemiological data provides a basis for genetic counseling and public health policies concerning G6PD deficiency in Yunnan.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...